Edition:
India

Biocartis: 5 Idylla Performance Studies To Be Presented At Congress


Monday, 23 Sep 2019 

Sept 23 (Reuters) - BIOCARTIS GROUP NV ::FIVE IDYLLA PERFORMANCE STUDIES TO BE PRESENTED AT ‘EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY’ CONGRESS.ALL STUDIES DEMONSTRATED EXCELLENT PERFORMANCE OF IDYLLA COMPARED TO OTHER METHODS, IN COMBINATION WITH EASE OF USE AND FAST TURNAROUND TIME OF THE IDYLLA PLATFORM.LAUNCH OF FULLY AUTOMATED IDYLLA CTEGFR MUTATION ASSAY FOR LIQUID BIOPSY TESTING OF EGFR MUTATIONS IS EXPECTED IN Q4 2019. 

Company Quote

5.88
0.04 +0.68%
6:52pm IST